Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific …
Read More
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that the first patient has been dosed in the Phase 1/2 GRECO-1 clinical trial of GC4711 in combination with stereotactic body …
Read More